Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
María José
García Velloso
Consultora Médica
Publicacións nas que colabora con María José García Velloso (46)
2023
-
Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440
-
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108
2022
-
11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value
International Journal of Molecular Sciences, Vol. 23, Núm. 17
2021
-
Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160
-
Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer
Cancers, Vol. 13, Núm. 14
-
Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma
Physica Medica, Vol. 84, pp. 1-9
2020
-
Article18 f-fdg and11 c-methionine pet/ct in newly diagnosed multiple myeloma patients: Comparison of volume-based pet biomarkers
Cancers, Vol. 12, Núm. 4
-
FDG PET/CT in colorectal cancer
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66
-
The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT
European Journal of Radiology, Vol. 133
2018
-
Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET
BMC Cancer, Vol. 18, Núm. 1
-
Evolution of Nuclear Medicine in the diagnosis and treatment of prostate cancer
Revista Espanola de Medicina Nuclear e Imagen Molecular
-
Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality
Physica Medica, Vol. 46, pp. 134-139
2017
-
11C-Methionine-PET in multiple myeloma: A combined study from two different institutions
Theranostics, Vol. 7, Núm. 11, pp. 2956-2964
-
Effective dose estimation for oncological and neurological PET/CT procedures
EJNMMI Research, Vol. 7, Núm. 1
-
MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer
European Radiology, Vol. 27, Núm. 8, pp. 3190-3198
-
Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury
Journal of Translational Medicine, Vol. 15, Núm. 1
2016
-
Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT
Lung Cancer, Vol. 97, pp. 81-86
2015
-
Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)
Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176
2014
-
Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
European Journal of Nuclear Medicine and Molecular Imaging
-
PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization
Medical Physics, Vol. 41, Núm. 9